Tenaya Therapeutics Newsroom

Promising Outlook for Tenaya Therapeutics: Buy Rating Justified by Innovative Gene Therapy Potential

TipRanksApr 25 06:17 ET · Ratings

Express News | Tenaya Therapeutics Reveals Interim Data From RIDGE Natural History And Seroprevalence Study Of Adults With PKP2-Associated ARVC At Heart Rhythm 2025

BenzingaApr 24 14:23 ET

Morgan Stanley Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsApr 1 14:31 ET · Ratings

Buy Rating Affirmed for Tenaya Therapeutics Amid Promising TN-201 Data and Financial Stability

TipRanksApr 1 06:16 ET · Ratings

LifeSci Capital Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsMar 31 14:32 ET · Ratings

William Blair Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating

Moomoo NewsMar 31 14:32 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $5 Price Target

BenzingaMar 31 10:38 ET

Tenaya Therapeutics Announces Late Breaker Presentation Of New Data From MyPEAK-1 Phase 1b/2 Clinical Trial Of TN-201 At American College Of Cardiology Annual Meeting

BenzingaMar 31 10:06 ET

Tenaya Therapeutics Announces Late Breaker Presentation of New Data From MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

GlobeNewswireMar 31 10:00 ET

Tenaya Therapeutics Announces Late Breaker Presentation of New Data From MyPEAK -1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

Globe NewswireMar 31 10:00 ET

Express News | Tenaya Therapeutics Inc - Expects to Recognize Charges by Q3 2025 - SEC Filing

ReutersMar 28 16:12 ET

Express News | Tenaya Therapeutics Inc - on Mar 27, Co Approves Restructuring Plan - SEC Filing

ReutersMar 28 16:10 ET

SA Asks: Which Small/mid-cap Cardiology Stocks Are Undervalued?

Seeking AlphaMar 28 15:16 ET

CCORF Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Cuts Target Price to $6

Moomoo NewsMar 25 15:31 ET · Ratings

Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March

Yahoo FinanceMar 25 11:27 ET

Promising Developments in Tenaya Therapeutics' TN-201 Program Justify Buy Rating

TipRanksMar 25 06:46 ET · Ratings

Tenaya Therapeutics Says Gene Therapy Candidate Improves Heart Function in Preclinical Trial

MT NewswiresMar 24 09:22 ET

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Stock Price Dropped 13% Last Week; Individual Investors Would Not Be Happy

Yahoo FinanceMar 24 08:52 ET

Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

GlobeNewswireMar 24 08:30 ET

Express News | Tenaya Therapeutics Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

ReutersMar 21 16:11 ET